| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 39 |
| 1 | DEXAMETHASONE | 22 |
| 2 | DEXAMETHASONE 1.5 MG | 22 |
| 3 | LENALIDOMIDE | 18 |
| 4 | MYCOPHENOLATE MOFETIL | 18 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 18 |
| 6 | ETOPOSIDE | 16 |
| 7 | TACROLIMUS | 14 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 9 | TACROLIMUS OINTMENT 0.1% | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 1 | PYRIMETHAMINE | 3 | 0.0024 |
| 2 | DINUTUXIMAB | 2 | 0.0023 |
| 3 | GLASDEGIB | 1 | 0.0021 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 14 | 0.0017 |
| 5 | NITROFURANTOIN (MACROCRYSTALS) | 1 | 0.0016 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 7 | MANNITOL | 6 | 0.0012 |
| 8 | CLINDAMYCIN PHOSPHATE | 6 | 0.0011 |
| 9 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 64 |
| 1 | Thalidomide Analog [EPC] | 20 |
| 2 | Alkylating Drug [EPC] | 18 |
| 3 | Kinase Inhibitor [EPC] | 18 |
| 4 | Topoisomerase Inhibitor [EPC] | 18 |
| 5 | Platinum-based Drug [EPC] | 17 |
| 6 | Fluoroquinolone Antibacterial [EPC] | 14 |
| 7 | Glycopeptide Antibacterial [EPC] | 13 |
| 8 | Janus Kinase Inhibitor [EPC] | 13 |
| 9 | Loop Diuretic [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 2 | Osmotic Diuretic [EPC] | 6 | 0.0011 |
| 3 | Sulfonamide Antibacterial [EPC] | 4 | 0.0010 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 6 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 7 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 8 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 9 | Penem Antibacterial [EPC] | 10 | 0.0003 |